» Articles » PMID: 23414411

Virus-like Particles Produced in Plants As Potential Vaccines

Overview
Date 2013 Feb 19
PMID 23414411
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Virus-like particles (VLPs) have been produced as candidate vaccines in plants virtually since the introduction of biofarming. Even today, VLPs remain the best candidates for safe, immunogenic, efficacious and inexpensive vaccines. Well-characterized human animal viruses such as HBV, HCV, HIV and HPV, rotaviruses, norovirus, foot and mouth disease viruses and even influenza virus proteins have all been successfully investigated for VLP formation. Proteins have been produced in transgenic plants and via transient expression techniques; simple structures, structures depending on more than one protein, naked and enveloped particles have all been made. There have been multiple proofs of concept, more than a few proofs of efficacy, and several products moved into human trials. This review will cover the history of VLP production in plants, and will explore a few examples in detail to illustrate the potential of such a mode of production for human and animal medicine.

Citing Articles

The Role of Plant Virus-like Particles in Advanced Drug Delivery and Vaccine Development: Structural Attributes and Application Potential.

Peralta-Cuevas E, Garcia-Atutxa I, Huerta-Saquero A, Villanueva-Flores F Viruses. 2025; 17(2).

PMID: 40006903 PMC: 11861432. DOI: 10.3390/v17020148.


Highly stable L-BC capsids with versatile packing potential.

Celitan E, Staneviciene R, Serviene E, Serva S Front Bioeng Biotechnol. 2024; 12:1456453.

PMID: 39386045 PMC: 11461329. DOI: 10.3389/fbioe.2024.1456453.


Optimization, characterization, comparison of self-assembly VLP of capsid protein L1 in yeast and reverse vaccinology design against human papillomavirus type 52.

Firdaus M, Mustopa A, Ekawati N, Chairunnisa S, Arifah R, Hertati A J Genet Eng Biotechnol. 2023; 21(1):68.

PMID: 37222880 PMC: 10206359. DOI: 10.1186/s43141-023-00514-9.


Generation of multi-layered protein bodies in for the encapsulation of vaccine antigens.

Schwestka J, Zeh L, Tschofen M, Schubert F, Arcalis E, Esteve-Gasent M Front Plant Sci. 2023; 14:1109270.

PMID: 36733717 PMC: 9887037. DOI: 10.3389/fpls.2023.1109270.


Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance.

Jimenez-Cabello L, Utrilla-Trigo S, Barreiro-Pineiro N, Pose-Boirazian T, Martinez-Costas J, Marin-Lopez A Vaccines (Basel). 2022; 10(7).

PMID: 35891288 PMC: 9319458. DOI: 10.3390/vaccines10071124.